Two innovative mechanisms have been used to accelerate the development of low-price supply lines for conjugate vaccines. The Meningitis Vaccine Project is a so-called push mechanism that facilitated technology transfer to an Indian company to establish capacity to manufacture a vaccine. The Advanced Market Commitment for pneumococcal vaccines is a so-called pull mechanism that guarantees companies a supplement paid in addition to the purchase price for vaccines for a specific period. This article, published in The Lancet, compares these approaches, identifying key dimensions of each and considering their potential for replication. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.) 

Author(s): Hargreaves JR, Greenwood B, Clift C, et al.

Published: 2011

Resource types: Peer-reviewed journal

Diseases: Meningococcus; Pneumococcus

Topics: Immunization financing; Disease/vaccine specific information

Regions: Global